MX362187B - Microesferas de liberacion sostenida y metodo para producir las mismas. - Google Patents
Microesferas de liberacion sostenida y metodo para producir las mismas.Info
- Publication number
- MX362187B MX362187B MX2015012231A MX2015012231A MX362187B MX 362187 B MX362187 B MX 362187B MX 2015012231 A MX2015012231 A MX 2015012231A MX 2015012231 A MX2015012231 A MX 2015012231A MX 362187 B MX362187 B MX 362187B
- Authority
- MX
- Mexico
- Prior art keywords
- dispersed phase
- sustained release
- filtering
- producing
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Manufacturing Of Micro-Capsules (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361790554P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/028657 WO2014144309A1 (en) | 2013-03-15 | 2014-03-14 | Sustained release microspheres and method of producing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2015012231A MX2015012231A (es) | 2016-05-05 |
| MX362187B true MX362187B (es) | 2019-01-08 |
Family
ID=51537672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015012231A MX362187B (es) | 2013-03-15 | 2014-03-14 | Microesferas de liberacion sostenida y metodo para producir las mismas. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9956177B2 (https=) |
| EP (1) | EP2968184B1 (https=) |
| JP (2) | JP2016515517A (https=) |
| CN (1) | CN105705141B (https=) |
| CA (1) | CA2909303C (https=) |
| ES (1) | ES2697696T3 (https=) |
| MX (1) | MX362187B (https=) |
| WO (1) | WO2014144309A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9956177B2 (en) | 2013-03-15 | 2018-05-01 | Oakwood Laboratories LLC | Sustained release microspheres and method of producing same |
| CN113766952B (zh) * | 2019-03-29 | 2023-09-08 | 国立研究开发法人量子科学技术研究开发机构 | 放射性药品的制造方法及放射性药品 |
| JP2023551508A (ja) * | 2020-11-30 | 2023-12-08 | エルジー・ケム・リミテッド | カスパーゼ阻害剤を含有する注射用組成物及びその製造方法 |
| US11992559B2 (en) | 2021-02-24 | 2024-05-28 | Oakwood Laboratories, Llc | Microsphere formulations comprising lurasidone and methods for making and using the same |
| US20240148662A1 (en) * | 2021-03-11 | 2024-05-09 | Oakwood Laboratories, Llc | Methods and systems for making polymer microspheres |
| CN116999412A (zh) * | 2023-08-03 | 2023-11-07 | 四川迈可隆生物科技有限公司 | 一种含有倍他米松药物的缓释微球制剂及其制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5945125A (en) | 1995-02-28 | 1999-08-31 | Temple University | Controlled release tablet |
| US6046187A (en) * | 1996-09-16 | 2000-04-04 | Children's Medical Center Corporation | Formulations and methods for providing prolonged local anesthesia |
| SE9704186D0 (sv) * | 1997-11-14 | 1997-11-14 | Astra Ab | New composition of matter |
| US6270802B1 (en) | 1998-10-28 | 2001-08-07 | Oakwood Laboratories L.L.C. | Method and apparatus for formulating microspheres and microcapsules |
| WO2002078673A1 (fr) * | 2001-03-29 | 2002-10-10 | Takeda Chemical Industries, Ltd. | Procede de production d'un medicament sous forme de granules fins |
| JP2002356419A (ja) * | 2001-03-29 | 2002-12-13 | Takeda Chem Ind Ltd | 微粒薬物の製造法 |
| WO2005107714A2 (en) * | 2004-05-05 | 2005-11-17 | Alkermes Controlled Therapeutics, Inc. | Method of forming microparticles that include a bisphosphonate and a polymer |
| GB2459910B (en) | 2008-04-21 | 2010-03-31 | Otonomy Inc | Controlled Release Corticosteroid Compositions and Methods for the Treatment of Otic Disorders |
| US20100086596A1 (en) * | 2008-10-06 | 2010-04-08 | Oakwood Laboratories LLC | Microspheres for releasing an octreotide compound without an initial time lag |
| US8343498B2 (en) * | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
| UA111162C2 (uk) * | 2010-08-04 | 2016-04-11 | Флекшен Терап'Ютікс, Інк. | Ін'єкційна композиція ацетоніду триамцинолону для лікування болю |
| US8708159B2 (en) * | 2011-02-16 | 2014-04-29 | Oakwood Laboratories, Llc | Manufacture of microspheres using a hydrocyclone |
| US9956177B2 (en) | 2013-03-15 | 2018-05-01 | Oakwood Laboratories LLC | Sustained release microspheres and method of producing same |
-
2014
- 2014-03-14 US US14/774,851 patent/US9956177B2/en active Active
- 2014-03-14 EP EP14762738.4A patent/EP2968184B1/en active Active
- 2014-03-14 WO PCT/US2014/028657 patent/WO2014144309A1/en not_active Ceased
- 2014-03-14 CN CN201480016260.6A patent/CN105705141B/zh active Active
- 2014-03-14 JP JP2016502862A patent/JP2016515517A/ja active Pending
- 2014-03-14 ES ES14762738T patent/ES2697696T3/es active Active
- 2014-03-14 MX MX2015012231A patent/MX362187B/es active IP Right Grant
- 2014-03-14 CA CA2909303A patent/CA2909303C/en active Active
-
2019
- 2019-04-19 JP JP2019080106A patent/JP6808777B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2909303C (en) | 2021-10-19 |
| MX2015012231A (es) | 2016-05-05 |
| JP2016515517A (ja) | 2016-05-30 |
| EP2968184B1 (en) | 2018-10-24 |
| US20160030351A1 (en) | 2016-02-04 |
| ES2697696T3 (es) | 2019-01-25 |
| JP6808777B2 (ja) | 2021-01-06 |
| BR112015022524A2 (pt) | 2017-08-22 |
| JP2019112471A (ja) | 2019-07-11 |
| WO2014144309A1 (en) | 2014-09-18 |
| CN105705141A (zh) | 2016-06-22 |
| EP2968184A4 (en) | 2016-09-07 |
| CA2909303A1 (en) | 2014-09-18 |
| CN105705141B (zh) | 2018-12-28 |
| EP2968184A1 (en) | 2016-01-20 |
| US9956177B2 (en) | 2018-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX362187B (es) | Microesferas de liberacion sostenida y metodo para producir las mismas. | |
| EP3354649A4 (en) | Oxa spiro derivative, preparation method therefor, and applications thereof in medicines | |
| EP3283919A4 (en) | Systems and methods for producing objects incorporating selectably active electromagnetic energy filtering layers | |
| WO2013105101A8 (en) | Solid lipid nanoparticles entrapping hydrophilic/ amphiphilic drug and a process for preparing the same | |
| EP3162434A4 (en) | Hollow particles, method for producing same, use thereof, and method for producing microcapsule particles | |
| MX2015012232A (es) | Microesferas de buprenorfina de fuerte carga de medicamento y su metodo de fabricacion. | |
| WO2016098910A8 (en) | Composite particle and preparation thereof | |
| EP3297074A4 (en) | Three-dimensional mesh structure form electrode for electrochemical device, method for producing same, and electrochemical device comprising same | |
| WO2015058664A8 (zh) | 淫羊藿苷元在制备预防或治疗血细胞减少药物中的用途 | |
| IL242468B (en) | A method for stabilizing suspensions of red blood cells encapsulating an active substance, the resulting suspension | |
| HK1217650A1 (zh) | 用於治疗剧痛的组合物及方法 | |
| EP3222667A4 (en) | Spherical monodispersible polyester resin aqueous dispersion, method for producing same, spherical monodispersible polyester resin particle, and cosmetic product | |
| WO2015048757A3 (en) | Foam formulations and apparatus for delivery | |
| FI20135467A7 (fi) | Glykolihappopolymeerit ja menetelmä niiden valmistamiseksi | |
| WO2016193924A3 (en) | System of multiple bags and method for the preparation of hemocomponents | |
| WO2015107544A3 (en) | Pharmaceutical microemulsion immobilized in a thin polymer matrix and methods of making them | |
| SMT202200275T1 (it) | Nanoparticelle quali veicoli di rilascio di principi attivi e metodi per la loro produzione | |
| WO2014060443A3 (en) | A composite scaffold for use as a tissue engineering implant | |
| HK1203824A1 (en) | Hydrocortisone controlled release formulation | |
| GB2504573B (en) | Panel acting as active retarder, method of fabricating the same, and 3-dimensional stereoscopic image displayable system including the panel | |
| WO2015054576A3 (en) | System and method for manufacturing encapsulate compositions | |
| EP3352750A4 (en) | Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient | |
| EP3138554B8 (en) | Microcapsule formulation and method for producing the same | |
| EP3011965A4 (en) | Salvia miltiorrhiza extract, micropellet formulation thereof, methods of preparing same, and uses thereof | |
| MX2016006738A (es) | Procedimiento para producir material particulado inorganico. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |